MacroChem Corporation (OTC Bulletin Board: MACM) announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical antifungal lacquer for the treatment of onychomycosis (nail fungus).
This post is an original post by ScienceDaily: Skin Care News